Viking Therapeutics, Inc. announced positive top-line results from the companys maintenance study of VK2735, the companys (GLP-1) and g ...
Viking Therapeutics Stock Surges 35%. It Could Challenge Lilly and Novo's Obesity Empire. On Tiger Brokers' website to stay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results